Black children face rising type 2 diabetes risk. Learn to spot early warning signs, understand complications, and discover ...

Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth ...

Ozempic ingredient linked to dangerous eye condition that could threaten sight - Higher risk of developing nonarteritic ...

UTC+8Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8MFirst-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

One of the aims of metabolomics research is to identify the mechanisms involved in the development and progress of a disease. The significance of prevention, treatment and slowing down the progression ...